Clinical Trials Logo

BPH clinical trials

View clinical trials related to BPH.

Filter by:

NCT ID: NCT06351579 Not yet recruiting - Clinical trials for Stress Urinary Incontinence

Data Collection Post Radical Prostatectomy

ALTO
Start date: June 15, 2024
Phase:
Study type: Observational

The study is to collect information on patients undergoing radical prostatectomy (RP), with a primary focus on the occurrence, duration, and severity of post-prostatectomy incontinence. Data will be collected at multiple time points, allowing for a dynamic understanding of urinary incontinence patterns at post RP.

NCT ID: NCT06323109 Recruiting - Clinical trials for Lower Urinary Tract Symptoms

US Imaging for the Assessment of LUTS

Start date: November 28, 2023
Phase:
Study type: Observational

The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI)-UDS evaluation. Both US and MRI are non-invasive imaging techniques, but US is a more cost-effective and widely available technology. 80 participants will be enrolled and will be on study for up to 2.5 hours (1.5 hour MRI and 1 hour US).

NCT ID: NCT05914519 Not yet recruiting - BPH Clinical Trials

Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the outcomes and efficacy of ejaculatory preserving TURP in terms of voiding, erectile function, and ejaculation.

NCT ID: NCT05910983 Not yet recruiting - Overactive Bladder Clinical Trials

Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity

BPH Botox
Start date: January 1, 2025
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of intravesical Botox injections on lower urinary tract symptoms (LUTS) when administered during Bipolar prostate enucleation surgery in patients with bladder outlet obstruction (BOO) and overactive bladder symptoms (OAB).

NCT ID: NCT05818670 Completed - BPH Clinical Trials

Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study

Start date: November 11, 2020
Phase: Phase 4
Study type: Interventional

Comparison between tamsulosin and Tadalafil in management of benign prostatic hyperplasia A Randomised Trial

NCT ID: NCT05719220 Not yet recruiting - Clinical trials for Urinary Incontinence

Effect of Group Preoperative Pelvic Floor Training for HoLEP

Start date: June 2023
Phase:
Study type: Observational

The main goal of this study is to see if group pelvic floor training before surgery can help prevent urinary incontinence after Holmium laser enucleation of the prostate (HoLEP) surgery. The study has the potential to inform preoperative intervention strategies for managing incontinence after HoLEP.

NCT ID: NCT05628025 Completed - BPH Clinical Trials

Simulation-Based Enucleation Training: Initial Experience Using 3D-printed Organ Phantoms

Start date: November 23, 2021
Phase:
Study type: Observational

There are many possible surgical treatments when a patient presents with lower urinary tract symptoms due to an enlarged prostate, termed benign prostatic hyperplasia or BPH. One technique consists of using a laser to remove prostatic tissue through the penis, called laser enucleation of the prostate or LEP. LEP also has excellent properties to reduce blood loss and results in shorter hospital stays. Trainees must observe and perform several procedures before mastering the LEP technique. Different models have been used to mimic the LEP experience for surgeon trainees, such as virtual simulators or synthetic models. While these simulators offer an alternative to LEP procedures on real patients, they may lack realism which renders the simulator less representative than the real procedure.The 3D-printed prostate model of the present study mimics the properties of real-life prostatic tissue. In the setting of the MasterClass, trainees will perform LEP on the 3D models under the supervision of three experts. While the 3D organ phantom has been used to practice performing other procedures, this is the first time it will evaluated for LEP training. For this reason, the investigators will be assessing this model as a training tool.

NCT ID: NCT05620784 Recruiting - BPH Clinical Trials

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

Start date: March 1, 2023
Phase: Phase 3
Study type: Interventional

Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent treatment option for benign prostatic hypertrophy (BPH) as recommended by the American Urological Association (AUA) Guidelines. Loop diuretics (furosemide) have been given historically during the morcellation portion of HoLEP to promote urine production in the post-operative setting and to minimize the impact of fluid absorption during long periods of morcellation. The intra-operative use of 20mg IV furosemide in perioperative HoLEP pathways has been propagated with the dissemination of HoLEP across North America without evidence to support its routine administration. With increasing surgical efficiency from improvements in laser and morcellator technology, the role of intra-operative furosemide is unknown. This study is designed to assess if there is a significant difference in same day discharge rates after Holmium Laser Enucleation of the Prostate (HoLEP) with and without IV furosemide. .

NCT ID: NCT05422677 Completed - Clinical trials for Benign Prostatic Hyperplasia

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Start date: July 15, 2019
Phase:
Study type: Observational

In this study, BPH patients visited the institutions during the study period and the effectiveness and safety of the treatment of Tamsulosin(Hanmi Tams® Capsule) in real-practice. During the routine medical visit, according to the investigator's judgment, with diagnosis that the Tamsulosin prescription is appropriate, and after deciding to start treatment, patients with BPH who agreed to participate in the study were administered Tamsulosin. As this study is a non-interventional observational study, all subjects received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.

NCT ID: NCT05401032 Not yet recruiting - BPH Clinical Trials

Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients With BPH.

TryptoBPH
Start date: June 2022
Phase: Phase 2
Study type: Interventional

Benign prostatic hyperplasia (BPH) is one of the most prevalent human diseases and a major cause of lower urinary tract symptoms (LUTS). Some men respond to current medical treatment (mainly α-1 adrenoreceptor antagonists and 5 α-reductase inhibitors), but a large proportion of patients continues to need a surgical procedure to treat resistant LUTS or even more serious complications of BPH, creating the emerging necessity for novel pharmacological therapies. Oxitriptan may have a possible positive effect on BPH associated symptoms with probably no impact in sexual function (which is a common side effect of the current drugs for BPH associated symptoms). Also, improvement in symptoms could be higher than that of current drugs used for this condition. This is a single-center parallel group, randomized clinical trial. The study will take place in Hospital de Braga (Urology department). Eligible patients will be randomized to receive tamsulosin 0.4mg (once a day, q.d.) or 5-HTP (5-hidroxitriptophan) 100mg (three times a day, t.i.d.), for 6 months.